Moraga Lab Profile
Moraga Lab

@LabMoraga

Followers
149
Following
397
Media
1
Statuses
101

The Moraga group studies cytokines and their central role in immune regulation. We combine protein engineering, structural biology & immunology in our research

University of Dundee
Joined May 2019
Don't wanna be here? Send us removal request.
@BubeckLab
Bubeck Lab
2 years
After a hard year, I’m glad to see this finally over the line. A real team effort from ⁦@YiboJin@scott_d_gardner⁩ ⁦@TomasVoisin and others from ⁦@LabMoraga. As always, amazing data collection support ⁦@eBIC_Diamond#cryoem
1
11
43
@LabWaggoner
Waggoner Lab
2 years
Disease-associated variant in IL6ST gene encoding for gp130 led to increased flexibility including motion within the cytokine-binding core (IL-6 and IL-11) and increased distance between extracellular domains https://t.co/nPepamjV5m
0
3
13
@LabMoraga
Moraga Lab
2 years
Excited to share our newest full collaboration with @BubeckLab. We provide structural insights that help explain how mutations in gp130 that do not disrupt cytokine binding cause signaling defects and immunodeficiencies in humans. https://t.co/EF0OrJcx76, @UoDCellSigImm
0
7
27
@CytokineSociety
ICIS 🦋 @cytokinesociety.bsky.social
2 years
#Cytokines2023 Metabollix and friends, thanks so much @laoneill111
0
4
33
@hitchcock_lab
Hitchcock Lab
2 years
🚨2 Yr Postdoc Available🚨 Jointly supervised with @scienceadvocacy working on normal and pathological HSCs, cytokines, malignancy, clonal expansion. Come and join us at the newly-formed @CBR_UoY @YBRI_UoY Apply here 👇👇👇 https://t.co/5rVf8SYmmH Pls retweet and DM!
0
23
31
@biorxivpreprint
bioRxiv
2 years
Differential functional coupling in Gp130-JAK complexes expands the plasticity of the interleukin-6 signaling axis https://t.co/uWuBLVt5Iu #bioRxiv
0
2
2
@LabMoraga
Moraga Lab
2 years
Ever wonder why ancestral cytokine receptors, like Gp130, bind multiple JAKs, and whether the identity of the GP130-JAK complex instructs specific responses? Check our new work, in a full collaboration with the @PiehlerLab, for some answers https://t.co/SvuaVihj0z
0
4
9
@FEBSJournal
The FEBS Journal
2 years
📜State-of-the-Art📜 Molecular and cellular factors determining the functional pleiotropy of cytokines 🖋️ By Alison McFarlane, Elizabeth Pohler and Ignacio Moraga from @dundeeuni 🔗 https://t.co/zW2BxM6b3x #cytokinesignalling #endosomessignalling
0
2
8
@DrJuanLMendoza
Juan L. Mendoza
3 years
So excited for this session, I couldn’t sleep! Cytokines, engineering, structures, and therapies. Not a session to miss! 10:15 AM-12:15 PM room 102AB
@KingOfPathogens
ChrisHunter
3 years
Attending @ImmunologyAAI this week and love cytokines? @CytokineSociety: Modulating Cytokine Activity through Structural Knowledge – Saturday; 10:15 AM – 12:15 PM; Room 102AB. Organized by @DrJuanLMendoza with lots of cool cytokine engineering @SpanglerLab @Regeneron
0
2
6
@c_garbers
C. Garbers
3 years
Interested in interleukin-6 and how you can therapeutically block its pro-inflammatory activities? See our latest review, just published in @NatRevImmunol — great team work together with @Lab_Jenkins, Stefan Rose-John @kieluni and Jens Moll/Jürgen Scheller @HHU_de
@NatRevImmunol
Nature Rev Immunol
3 years
Targeting IL-6 trans-signalling: past, present and future prospects https://t.co/u8d1VTdnfV
2
6
20
@DrJuanLMendoza
Juan L. Mendoza
3 years
Join us for the ICIS-sponsored and organized session at Immunity 2023! Learn how both academic and industry members of ICIS are advancing our understanding of cytokine biology and developing future immunotherapeutics.
@CytokineSociety
ICIS 🦋 @cytokinesociety.bsky.social
3 years
Going to AAI? Please join us for the ICIS Guest Symposium "Understanding and Modulating Cytokine Activity through Structural Knowledge" @DrJuanLMendoza Saturday, May 13; 10:15 AM – 12:15 PM Eastern Time in Room 102AB https://t.co/bn6a2ZjVFI via @httpstwittercomCytokineSociety
0
2
7
@CytokineSociety
ICIS 🦋 @cytokinesociety.bsky.social
3 years
Going to AAI? Please join us for the ICIS Guest Symposium "Understanding and Modulating Cytokine Activity through Structural Knowledge" @DrJuanLMendoza Saturday, May 13; 10:15 AM – 12:15 PM Eastern Time in Room 102AB https://t.co/bn6a2ZjVFI via @httpstwittercomCytokineSociety
0
4
8
@IforRWilliams
Ifor Williams
3 years
NEW for 2023 on the @SciImmunology website is the dedicated CANCER IMMUNOLOGY block. 🔗➡️ https://t.co/rpcxdGgLOz Scroll down to it & check out 6 recent #cancerimmunology papers. More exciting new content is on the way to this space soon!
0
8
33
@Inserm
Inserm
3 years
#Cancer L’acidité des tumeurs nuit à l’efficacité des thérapies anticancéreuses, selon une nouvelle étude. Des résultats qui pourraient conduire à une nouvelle génération de traitements d’immunothérapie. ➡️ https://t.co/59sFZaU3L7
0
15
42
@ACIR_org
ACIR
3 years
SPOTLIGHT: After showing that tumor-derived lactic acid limited IL-2 signaling, STAT5 phosphorylation, and antitumor activity in the TME, @Inserm @at_Mitralab used directed evolution to identify a pH-selective IL-2 mutein that bound IL-2Rα with [...] 👉 https://t.co/qm9G2tiprU
0
5
16
@chngin_the_wrld
Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️
3 years
Today's #shoutout to #womeninSTEM goes to SILVIA GAGGERO for her @SciImmunology paper w/ @at_Mitralab showing IL-2 is inactivated by the acidic pH environment of #tumors enabling engineering of a pH-selective mutein.
Tweet card summary image
science.org
An engineered pH-selective IL-2 mutein augments cancer immunity in the acidic tumor microenvironment with limited systemic toxicity.
1
5
14
@ScienceMagazine
Science Magazine
3 years
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more in @SciImmunology: https://t.co/n4I62UsFZ9
0
15
68
@ScienceMagazine
Science Magazine
3 years
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more in @SciImmunology: https://t.co/eX4NLqgY1p
1
9
60
@apoptosislab
Muñoz-Pinedo/Ernest Nadal - PRETT lab
3 years
Another straightforward reason why the Warburg metabolism causes immune suppression in the TME IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein
1
11
30
@SciImmunology
Science Immunology
3 years
A new study looks to make IL-2 therapy more effective in tumors, presenting a variant of the cytokine that retains its binding affinity in low pH environments. Read more: https://t.co/z6vAT8dILJ @roychoudhurilab @LabMoraga @at_Mitralab @Inserm @Canther_Lille @CamPathology
0
11
21